Skip to content

Olema Pharmaceuticals, Inc. OLMA Line of Credit Outstanding

Line of Credit Outstanding at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$40M-38.5%

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$998.38M+253%
Enterprise value$946.79M+306%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermLineOfCredit.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s line of credit outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s line of credit outstanding?
Olema Pharmaceuticals, Inc. (OLMA) reported line of credit outstanding of $3M in Q1 2026.
What does line of credit outstanding mean?
This metric represents the total principal amount drawn and currently owed by the company under a revolving credit facility or similar short-term borrowing arrangement. It serves as a measure of the company's reliance on external debt financing to manage working capital requirements or fund operational activities. A higher balance indicates increased utilization of debt capacity, which may impact the company's liquidity profile and interest expense obligations.